Page last updated: 2024-11-06

6-methylthiopurine and Exanthema

6-methylthiopurine has been researched along with Exanthema in 1 studies

6-methylthiopurine : A thiopurine that is 9H-purine substituted by a methylsulfanyl group at position 6.

Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.

Research Excerpts

ExcerptRelevanceReference
"6-mercaptopurine is a mainstay of acute lymphoblastic leukemia treatment."1.72Acral Skin Rash Caused by Altered Mercaptopurine Metabolism in Maintenance Therapy for B-Cell Acute Lymphoblastic Leukemia. ( Alexander, TB; Geib, KB; Gold, S; Newcome, J; Thompson, P, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Newcome, J1
Geib, KB1
Thompson, P1
Gold, S1
Alexander, TB1

Other Studies

1 other study available for 6-methylthiopurine and Exanthema

ArticleYear
Acral Skin Rash Caused by Altered Mercaptopurine Metabolism in Maintenance Therapy for B-Cell Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2022, 10-01, Volume: 44, Issue:7

    Topics: Allopurinol; Burkitt Lymphoma; Child; Exanthema; Humans; Mercaptopurine; Precursor Cell Lymphoblasti

2022